Netherlands · Health and Youth Care Inspectorate · Medical devices
Review target
-
Not published
Legal time limit
-
Not published
Steps
4
9 requirements
Application fee
€62
current
Devices and IVDs follow the EU regulations. Only a few matters, such as supervision and the language of the instructions, are set nationally. Economic operators register in EUDAMED, and for Dutch actors the CIBG/Farmatec checks the request and issues the single registration number. The inspectorate (IGJ) supervises the market and receives incident reports until EUDAMED is ready. Any device, IVD or software device placed on the Dutch market, and manufacturers or importers established in the Netherlands.
The certificate of free sale (per certificate) is €62 for current.
1. Actor registration and SRN; 2. Conformity assessment under EU rules; 3. Place on the Dutch market with Dutch information; 4. Incident reporting and supervision.
Outcome: Registration number (SRN) for Dutch actors and lawful supply on the Dutch market.
Legal basis: Wet medische hulpmiddelen; Besluit medische hulpmiddelen; Regeling medische hulpmiddelen; Regulations (EU) 2017/745 and 2017/746
Each box is one step; arrows show the order. Dashed boxes happen only in some cases; the orange arrows go back (for example after questions).
Official step durations
In order, with the official target for each step
What the applicant must provide or meet
Targets, not actual review times
| No time targets published. |
Official amounts in the local currency
| Fee | Amount |
|---|---|
| Certificate of free sale (per certificate)Other · current | €62 |
Other routes in Netherlands: National derogation for a device without completed conformity assessment, CBG consultation on a medicinal substance in a device. See all routes on the Netherlands page or explore them in the Regulatory section.
Not legal or regulatory advice. Check the current official rules before you act. This summary was checked against the official laws, regulations and regulator guidance on October 3, 2026 (16 facts checked). Parts of the approvals data are official open data reused under open licences. Data sources.